Yuki Noguchi
👤 SpeakerAppearances Over Time
Podcast Appearances
The White House has been pressuring drug makers to equalize U.S.
The administration says these agreements will lower Medicaid drug prices.
Consumers who pay out-of-pocket will also be able to get lower prices for some of the company's most popular drugs through a government website called TrumpRx.
Under the agreements, Amgen, Merck, GSK, and others will also invest $150 billion in U.S.
In exchange, the companies will be exempt from some of the administration's stiff tariffs for three years.
Dr. Michael Liu says recent data show only 1% of physicians in the U.S.
have work visas known as H-1B.
Those are for highly trained, highly skilled professionals, and those doctors work in some of the toughest communities.
Liu is Canadian and remained in the U.S.
after training here and getting married earlier this year.
Just in the past decade, there have been over 70 new drugs introduced to treat lung cancer.
That has led to enormous increases in the five-year survival rate among those with the disease, from 18 percent eight years ago to 30 percent today.
However, the report also says recent funding and staffing cuts to the National Institutes of Health
Centers for Disease Control and Prevention, as well as cuts to Medicaid and health care coverage, threaten this progress.
And racial inequalities persist.
Black, Latino, and Native American people are less likely to be diagnosed early, receive treatment, and survive the disease.